India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.

Noveltreat to be available in five dose strengths of 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL and 2.4 ...

DCGI approval to Sun Pharma comes amid an ongoing patent dispute with Novo Nordisk in the Delhi High Court. The case relates ...

Novo Nordisk, the Denmark based pharma giant, has finally launched its hugely popular diabetes and weight-loss medicine, Ozempic, in the Indian market. Ozempic has recently garnered global recognition ...

Obesity is fast emerging as one of India's biggest health challenges, driving diabetes, heart disease and other lifestyle ...

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection.

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Ozempic is now available in India as ...

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Ozempic is now available in India as ...

Ozempic Now In India: Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the 'FlexTouch Pen'. Ozempic Now In India: The ...

Cipla Limited announced on Wednesday that it has introduced Yurpeak, a once-weekly injectable treatment for obesity and type 2 diabetes, two rapidly growing health concerns in India. Yurpeak is the ...

New Delhi: Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Ozempic is now available in ...